Tag
Healthcare Diagnostics
9 articles
Healthcare diagnostics companies are demonstrating robust growth, fueled by expanding networks and increasing demand for testing services. Vijaya Diagnostic reported a significant 37.6% jump in Q1 profit, driven by strong volume growth, margin expansion, and strategic geographic expansion into Tier 2 and 3 cities. Metropolis Healthcare also posted a 16.6% revenue increase, benefiting from a focus on specialty testing and digital initiatives. While Aspira Diagnostics is considering a fundraising round and has undergone changes in its promoter category, the overall sector appears poised for continued expansion, supported by increasing healthcare awareness and accessibility.
Clinitech Laboratory 16th AGM Notice and FY26 Results
Clinitech Laboratory Limited issued notice for its 16th Annual General Meeting to be held on September 24, 2026 via video conference.
The company reported standalone revenue of ₹966.31 lakhs and net p
Vijaya Diagnostic Independent Director Tenure Completion
Dr. Manjula Anagani ceased as Non-Executive Independent Director of Vijaya Diagnostic Centre effective August 21, 2026.
The cessation occurred due to completion of her first five-year term without see
Krsnaa Diagnostics Preferential Warrant Issue of ₹91.75 Crore
Krsnaa Diagnostics discloses a preferential issue of up to 16.21 lakh warrants for ₹91.75 crore to two allottees.
The warrants are convertible into equity shares within 18 months at an issue price of
Thyrocare Share Pledge Released After ₹1,700 Cr NCD Redemption
Thyrocare Technologies discloses complete discharge of transaction documents after API Holdings fully redeemed ₹1,700 crore Non-Convertible Debentures.
Pledge over 60.92% of Thyrocare's equity shares
Krsnaa Diagnostics Q1 Revenue Up 22% YoY
Krsnaa Diagnostics reported 22% YoY revenue growth to INR 2,355 million for Q1 FY27, with EBITDA margin at 25%.
The company announced a new 34-CT scan project award in Himachal Pradesh, expanding its
Suraksha Diagnostic Q1 PAT Surges 40% to ₹128M
Suraksha Diagnostic reported Q1 FY27 revenue growth of 21% YoY to ₹887M with PAT up 40% to ₹128M.
The company expanded its network with 4 new centers and extended into Jharkhand, maintaining a target
Thyrocare Promoter Docon Sells 9.9% Stake
Promoter Docon Technologies sold 1.58 crore Thyrocare shares representing 9.9% equity via market trades on August 13, 2026.
Post-sale, promoter shareholding reduced from 60.92% to 51.02% of total paid
Thyrocare Promoter Releases Pledge on 17.5M Shares
Docon Technologies, Thyrocare's promoter, released pledge on 1.75 crore equity shares (10.99% stake) held as security for API Holdings' NCDs.
The pledge release on August 11, 2026, reduces Docon's enc
Aspira Pathlab Promoter Category Change Post-Open Offer
Aspira Pathlab intimates BSE of a change in promoter category following completion of an open offer.
Director Nikunj Mange is reclassified as a promoter upon completion of the open offer process.
Jay